Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort-Reference-Cited by-同舟云学术

Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort

Published:2022-03 Issue: Volume:114 Page:106794
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

de Pádua Covas Lage Luís Alberto,Brito Cláudio Vinícius,Levy Débora,Culler Hebert Fabrício,Freitas Couto Samuel Campanelli,de Oliveira Lucas Bassolli Alves,Nogueira Zerbini Maria Cláudia,Rocha Vanderson,Pereira Juliana

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference33 articles.

1. The 2016 revision of World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood,2016

2. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications;Campo;Blood,2011

3. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma;Iqbal;Blood,2014

4. T-cell lymphomas, a challenging disease: types, treatments and future;MA;Int J. Clin. Oncol.,2017

5. The problem with cyclophosphamide, doxorrubicin, vincristine and prednisone for the treatment of peripheral T-cell lymphoma;Kansara;Leuk. Lymphoma,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of the recommended immunohistochemistry algorithm for classification of peripheral T‐cell lymphoma, not otherwise specified into the prognostically significant GATA3 and TBX21 subtypes;International Journal of Laboratory Hematology;2024-06-14

2. Tumor mutation burden involving epigenetic regulatory genes and the RhoA GTPase predicts overall survival in nodal mature T-cell lymphomas;Clinical Epigenetics;2022-12

3. Identification of immune-related genes and development of a prognostic model in mantle cell lymphoma;Annals of Translational Medicine;2022-12

4. Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen–Results of a Real-Life Study From a Middle-Income Country;Clinical Lymphoma Myeloma and Leukemia;2022-11

5. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients;Cancer Biomarkers;2022-10-12